Cargando...
Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma
The combination of clarithromycin, lenalidomide and dexamethasone (BiRd) has led to highly durable responses in newly diagnosed myeloma. However, the ability of clarithromycin to overcome resistance to lenalidomide and dexamethasone (Rd) is not known. To study this, we performed a retrospective anal...
Gardado en:
| Publicado en: | Am J Hematol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4390045/ https://ncbi.nlm.nih.gov/pubmed/24723438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23733 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|